X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (21) 21
humans (18) 18
immunology (16) 16
oncology (15) 15
animals (13) 13
male (13) 13
cancer (12) 12
female (12) 12
mice (12) 12
middle aged (12) 12
adult (9) 9
melanoma (9) 9
aged (8) 8
drug therapy (8) 8
immunotherapy (8) 8
lymphocytes (8) 8
metastasis (7) 7
antigen (6) 6
expression (6) 6
mice, inbred c57bl (6) 6
mice, transgenic (6) 6
t cells (6) 6
treatment outcome (6) 6
analysis (5) 5
cancer regression (5) 5
carcinoma, renal cell - drug therapy (5) 5
cd8-positive t-lymphocytes - immunology (5) 5
kidney neoplasms - drug therapy (5) 5
medicine, research & experimental (5) 5
melanoma - drug therapy (5) 5
research (5) 5
t-cell responses (5) 5
adoptive transfer (4) 4
antineoplastic agents - therapeutic use (4) 4
article (4) 4
care and treatment (4) 4
chemotherapy (4) 4
clinical trials (4) 4
dendritic cells (4) 4
dosage and administration (4) 4
interferon-alpha (4) 4
metastatic melanoma (4) 4
pyrroles - therapeutic use (4) 4
receptor gene-therapy (4) 4
receptors, antigen, t-cell - genetics (4) 4
sunitinib (4) 4
survival (4) 4
t-lymphocytes - immunology (4) 4
toxicity (4) 4
tumors (4) 4
abridged index medicus (3) 3
aged, 80 and over (3) 3
antigens, neoplasm - immunology (3) 3
antineoplastic agents (3) 3
cancer research (3) 3
carcinoma, renal cell (3) 3
cd8 t-cells (3) 3
cd8-positive t-lymphocytes - metabolism (3) 3
clinical-trials (3) 3
combined modality therapy (3) 3
cyclophosphamide (3) 3
disease-free survival (3) 3
gene therapy (3) 3
in-vivo (3) 3
indoles - therapeutic use (3) 3
ipilimumab (3) 3
kaplan-meier estimate (3) 3
lymphocytes t (3) 3
melanoma - therapy (3) 3
melanoma, experimental - therapy (3) 3
patients (3) 3
peptide fragments - immunology (3) 3
renal-cell carcinoma (3) 3
skin cancer (3) 3
survival analysis (3) 3
t-lymphocytes, cytotoxic - immunology (3) 3
targeted therapy (3) 3
therapy (3) 3
transduction, genetic (3) 3
tumor-infiltrating lymphocytes (3) 3
tyrosine kinase inhibitor (3) 3
usage (3) 3
vaccination (3) 3
vaccines, dna - immunology (3) 3
viral core proteins - immunology (3) 3
adjuvant treatment (2) 2
administration, oral (2) 2
adoptive cell therapy (2) 2
adoptive transfer - methods (2) 2
amino acid sequence (2) 2
angiogenesis (2) 2
antibodies, monoclonal - adverse effects (2) 2
antigen presentation - genetics (2) 2
antigens, viral - genetics (2) 2
antigens, viral - immunology (2) 2
antimitotic agents (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
biomedicine (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9992, pp. 444 - 451
Journal Article
by Lundqvist, Andreas and van Hoef, Vincent and Zhang, Xiaonan and Wennerberg, Erik and Lorent, Julie and Witt, Kristina and Sanz, Laia Masvidal and Liang, Shuo and Murray, Shannon and Larsson, Ola and Kiessling, Rolf and Mao, Yumeng and Sidhom, John-William and Bessell, Catherine A and Havel, Jonathan and Schneck, Jonathan and Chan, Timothy A and Sachsenmeier, Eliot and Woods, David and Berglund, Anders and Ramakrishnan, Rupal and Sodre, Andressa and Weber, Jeffrey and Zappasodi, Roberta and Li, Yanyun and Qi, Jingjing and Wong, Philip and Sirard, Cynthia and Postow, Michael and Newman, Walter and Koon, Henry and Velcheti, Vamsidhar and Callahan, Margaret K and Wolchok, Jedd D and Merghoub, Taha and Lum, Lawrence G and Choi, Minsig and Thakur, Archana and Deol, Abhinav and Dyson, Gregory and Shields, Anthony and Haymaker, Cara and Uemura, Marc and Murthy, Ravi and James, Marihella and Wang, Daqing and Brevard, Julie and Monaghan, Catherine and Swann, Suzanne and Geib, James and Cornfeld, Mark and Chunduru, Srinivas and Agrawal, Sudhir and Yee, Cassian and Wargo, Jennifer and Patel, Sapna P and Amaria, Rodabe and Tawbi, Hussein and Glitza, Isabella and Woodman, Scott and Hwu, Wen-Jen and Davies, Michael A and Hwu, Patrick and Overwijk, Willem W and Bernatchez, Chantale and Diab, Adi and Massarelli, Erminia and Segal, Neil H and Ribrag, Vincent and Melero, Ignacio and Gangadhar, Tara C and Urba, Walter and Schadendorf, Dirk and Ferris, Robert L and Houot, Roch and Morschhauser, Franck and Logan, Theodore and Luke, Jason J and Sharfman, William and Barlesi, Fabrice and Ott, Patrick A and Mansi, Laura and Kummar, Shivaani and Salles, Gilles and Carpio, Cecilia and Meier, Roland and Krishnan, Suba and McDonald, Dan and Maurer, Matthew and Gu, Xuemin and Neely, Jaclyn and Suryawanshi, Satyendra and Levy, Ronald and Khushalani, Nikhil and Wu, Jennifer and Zhang, Jinyu and Basher, Fahmin and Rubinstein, Mark and Bucsek, Mark and Qiao, Guanxi and ...
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 11/2016, Volume 4, Issue S1
Journal Article
Ophthalmology, ISSN 0161-6420, 2015, Volume 122, Issue 9, pp. 1907 - 1916
Journal Article
The Journal of Immunology, ISSN 0022-1767, 10/2008, Volume 181, Issue 7, pp. 5128 - 5136
Journal Article
JAMA Oncology, ISSN 2374-2437, 02/2019, Volume 5, Issue 2, pp. 164 - 170
IMPORTANCE In clinical practice, patients with primary metastatic renal cell carcinoma (mRCC) have been offered cytoreductive nephrectomy (CN) followed by... 
TARGETED THERAPY | RADICAL NEPHRECTOMY | SURVIVAL | MORTALITY | INTERFERON-ALPHA | MORBIDITY | EFFICACY | ONCOLOGY | RESECTION | PLANNED NEPHRECTOMY | CANCER
Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2014, Volume 110, Issue 10, pp. 2441 - 2449
textabstractBackground:Plasma exposure of sunitinib shows large inter-individual variation. Therefore, a pharmacokinetic (PK) study was performed to determine... 
sunitinib | kinase and phosphatase inhibitors | TOXICITY | ANTITUMOR-ACTIVITY | INDIVIDUALIZATION | RENAL-CELL CARCINOMA | SU11248 | BREAST-CANCER | LUNG-CANCER | PHASE-II TRIAL | ONCOLOGY | personalised medicine | TYROSINE KINASE INHIBITOR | biodistribution/toxicology | therapeutic drug monitoring | pharmacokinetics and pharmacodynamics | ENDOTHELIAL GROWTH-FACTOR | Pyrroles - pharmacokinetics | Humans | Middle Aged | Salvage Therapy | Male | Fatigue - chemically induced | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Indoles - administration & dosage | Feasibility Studies | Dose-Response Relationship, Drug | Antineoplastic Agents - adverse effects | Pyrroles - administration & dosage | Pyrroles - adverse effects | Adult | Female | Antineoplastic Agents - pharmacokinetics | Protein Kinase Inhibitors - pharmacokinetics | Hematologic Diseases - chemically induced | Drug Administration Schedule | Indoles - blood | Neoplasms - enzymology | Pyrroles - blood | Protein Kinase Inhibitors - blood | Neoplasms - drug therapy | Protein Kinase Inhibitors - administration & dosage | Pilot Projects | Indoles - adverse effects | Antineoplastic Agents - blood | Indoles - pharmacokinetics | Nervous System Diseases - chemically induced | Aged | Drug Monitoring | Gastrointestinal Diseases - chemically induced | toxicology | biodistribution | Clinical Study
Journal Article
Journal Article
Journal Article
09/2015, Progress in Tumor Research, ISBN 9783318055894, Volume 42, 12
Book Chapter